KetoBreast: Comparison of Healthy Diets on Breast Cancer Markers

Sponsor
Albert Einstein College of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT02744079
Collaborator
(none)
11
1
2
26.1
0.4

Study Details

Study Description

Brief Summary

Women post breast mass biopsy with ER+or ER- cancer will be randomized to two diets--goal of 45 of them to a ketogenic insulin inhibiting diet, 20 to a low fat diet with whole grains and fruits and vegetables. The initial biopsy will be evaluated along with the surgical specimen pathology to compare changes in biomarkers, particularly of proliferation (Ki-67) and apoptosis (TUNEL).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Low carbohydrate diet
  • Behavioral: Low fat diet
N/A

Detailed Description

A healthy diet has been defined in various ways. The investigators wish to compare the effects of two diets on ER positive breast cancer tissues. The diets will be administered between the time of diagnosis and the time of surgical removal. Both diets have been proposed as healthy, but differ in their composition. One constitutes a low fat diet with extra fiber, fruits and vegetable servings, while the other comprises a diet low in carbohydrate content, aiming to lower insulin secretion. Patients will be randomized to each group, with 20 assigned to the low fat arm and 45 to the low carbohydrate arm.

Study Design

Study Type:
Interventional
Actual Enrollment :
11 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
A Pilot Presurgical Trial of Insulin Inhibition by a Ketogenic Diet in Operable Breast Cancer
Actual Study Start Date :
Jun 22, 2018
Actual Primary Completion Date :
Aug 25, 2020
Actual Study Completion Date :
Aug 25, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Low carbohydrate diet

45 subjects will receive a very low carbohydrate diet between a positive breast biopsy and surgical tumor removal

Behavioral: Low carbohydrate diet
45 subjects will be randomized to a dietary arm consisting of a complete, prepared very low carbohydrate diet, delivered to their homes, for the interval between positive breast biopsy and surgical tumor removal

Active Comparator: Low fat diet

20 subjects will receive a lo fat diet between a positive breast biopsy and surgical tumor removal

Behavioral: Low fat diet
20 subjects will be randomized to a dietary arm consisting of a complete, prepared low fat diet, delivered to their homes, for the interval between positive breast biopsy and surgical tumor removal.

Outcome Measures

Primary Outcome Measures

  1. TUNEL comparison of each dietary intervention at surgical removal to measure change in apoptosis in tumor cells [2 years]

  2. Ki-67 comparison of each dietary intervention at surgical removal to measure change in proliferation of tumor cells [2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Women with biopsy proven breast cancer.

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Albert Einstein College of Medicine of Yeshiva University Bronx New York United States 10461

Sponsors and Collaborators

  • Albert Einstein College of Medicine

Investigators

  • Principal Investigator: Eugene J Fine, MD, Albert Einstein College of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Eugene Fine, Professor of Radiology, Albert Einstein College of Medicine
ClinicalTrials.gov Identifier:
NCT02744079
Other Study ID Numbers:
  • 2016-6346
First Posted:
Apr 20, 2016
Last Update Posted:
Aug 31, 2020
Last Verified:
Aug 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Eugene Fine, Professor of Radiology, Albert Einstein College of Medicine
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 31, 2020